Internal Medicine, Medical Oncology · Sarasota, FL
NPI
1477879567
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1941 Waldemere St Fl 4
Sarasota, FL, 34239
Phone (941) 957-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
198,146 services
Medicare patients, 2024
1,020
Average age 77
Drug cost, 2024
$1.7M
1,432 prescriptions
Company payments, 2025
$872
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pavan Kumar Tandra was code J0185 (injection, aprepitant, 1 mg), 12,480 times for 29 patients. In total Pavan Kumar Tandra billed 198,146 services in 131 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0185 Injection, aprepitant, 1 mg | Office | 12,480 | 29 | $1.33 | $17K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,000 | 13 | $44.58 | $446K |
| J0897 Injection, denosumab, 1 mg | Office | 9,540 | 46 | $20.66 | $197K |
| J1756 Injection, iron sucrose, 1 mg | Office | 9,400 | 14 | $0.16 | $1,542 |
| J1434 Injection, fosaprepitant (focinvez), 1 mg | Office | 6,450 | 14 | $2.27 | $15K |
| Q5114 Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg | Office | 4,492 | 12 | $43.30 | $194K |
| J9171 Injection, docetaxel, 1 mg | Office | 4,083 | 11 | $0.70 | $2,846 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,700 | 35 | $15.62 | $58K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,198 | 53 | $0.09 | $199 |
| 99214 Office E&M - Established | Office | 1,775 | 538 | $94.10 | $167K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,600 | 39 | $0.75 | $1,207 |
| 85025 Blood Count | Office | 1,261 | 456 | $7.60 | $9,589 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,220 | 12 | $6.35 | $7,753 |
| 36415 Venipuncture Blood Collection | Office | 1,111 | 479 | $8.65 | $9,610 |
| Q5127 Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg | Office | 576 | 20 | $256.52 | $148K |
By year: 2022 $34K for 347 services; 2023 $2.0M for 126,831 services; 2024 $3.2M for 198,146 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,261 | 456 | $7.60 | $9,589 |
| 36415 Venipuncture Blood Collection | 1,111 | 479 | $8.65 | $9,610 |
| 85046 Blood Count | 295 | 222 | $5.46 | $1,611 |
Medicare prescription drug claims, 2024
In 2024, the drug Pavan Kumar Tandra prescribed most often to Medicare patients was Anastrozole, with 391 prescriptions and refills. In total Pavan Kumar Tandra wrote 1,432 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 391 | 1,102 | 130 | $8,019 |
| Tamoxifen Citrate Generic | 322 | 895 | 108 | $7,919 |
| Letrozole Generic | 147 | 402 | 55 | $3,481 |
| Ondansetron Odt Ondansetron | 44 | 44 | 27 | $945 |
| Prochlorperazine Maleate Generic | 44 | 47 | 27 | $344 |
| Dexamethasone Generic | 33 | 40 | 28 | $1,022 |
| Ibrance Palbociclib | 33 | 33 | Under 11 | $504K |
| Levofloxacin Generic | 24 | 24 | 19 | $157 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 20 | 33 | 17 | $228 |
| Exemestane Generic | 19 | 55 | Under 11 | $6,089 |
| Raloxifene Hcl Generic | 17 | 51 | Under 11 | $508 |
| Prednisone Generic | 17 | 23 | Under 11 | $107 |
| Ondansetron Hcl Generic | 16 | 16 | Under 11 | $186 |
| Loperamide Loperamide Hcl | 15 | 15 | 12 | $239 |
| Venlafaxine Hcl Generic | 14 | 40 | Under 11 | $337 |
Brand drugs: 130 claims; generic drugs: 1,302 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pavan Kumar Tandra $872 ($872 in general payments such as food, travel and fees) from 19 companies. The largest payer was Gilead Sciences, Inc. with $174.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 9 | $174 |
| Daiichi Sankyo Inc. 4568.T | 5 | $129 |
| Array Biopharma Inc PFE | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $64.99 |
| Pfizer Inc. PFE | 4 | $60.39 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $37.29 |
| Abbvie Inc. ABBV | 1 | $27.76 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.33 |
| Incyte Corporation INCY | 1 | $22.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.